Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack with an Intelligent System
The purpose of this study is to develop a digital health-based intelligent management system for the secondary prevention of ischemic stroke and to evaluate its effectiveness through a multicenter randomized controlled trial, assessing its health economic value. Participants will receive usual care after discharge (control group) or be managed with a WeChat-based intelligent management system after discharge (intervention group). At one year, all patients will undergo face-to-face follow-up to assess clinical events, medication adherence, and the achievement of target risk factor levels.
• Age ≥ 18 years.
• Patients diagnosed with acute ischemic stroke or transient ischemic attack.
• Time from onset to enrollment ≤ 14 days.
• Presence of at least one modifiable risk factor (hypertension, diabetes).
• Ability to independently use a smartphone to complete system tasks upon discharge, or with the assistance of family members.
• Discharge to home rather than to a community hospital, rehabilitation facility, or other professional medical institution.
• Signed informed consent by the patient or their family members.